Bills that would legalize medical cannabis have been filed in West Virginia’s House of Delegates and Senate.

March 06, 2017

Delegate Mike Pushkin (D) filed House Bill 2677, and Senator Richard Ojeda (D) filed Senate Bill 386. Both would legalize medical cannabis, albeit in different manners. HB 2688 has no cosponsors, whereas SB 386 is cosponsored by a bipartisan coalition of nine senators.

HB 2677 would legalize the possession of up to six ounces of cannabis, and the cultivation of up to 12 plants, for those with a qualifying condition who receive a recommendation from a physician. Qualifying conditions include:

(A) Cancer, glaucoma, positive status for human immunodeficiency virus, acquired immune deficiency syndrome, hepatitis C, amyotrophic lateral sclerosis, Crohn’s disease, agitation of Alzheimer’s disease, Parkinson’s disease, post-traumatic stress disorder, depression, anxiety, addiction to opiates or amphetamines or the treatment of these conditions;

(B) A chronic or debilitating disease or medical condition or its treatment that produces one or more of the following: Cachexia or wasting syndrome; severe or chronic pain; severe nausea; seizures; or severe and persistent muscle spasms, including, but not limited to, those characteristic of multiple sclerosis; or

(C) Any other medical condition or its treatment added by the department, as provided in section six of this article.

The proposal would established a system of licensed and regulated cannabis dispensaries, as a means of safe access to the medicine.

SB 386 would also legalize medical cannabis – including license dispensaries – but in a more limited way. Qualifying conditions include:

(A) A chronic or debilitating disease or medical condition that results in a patient being admitted into hospice or receiving palliative care; or

(B) A chronic or debilitating disease or medical condition or the treatment of a chronic or debilitating disease or medical condition that produces:

(i) Cachexia, anorexia, or wasting syndrome;

(ii) Severe or chronic pain that does not find effective relief through standard pain medication;

(iii) Severe nausea;

(iv) Seizures; or

(v) Severe or persistent muscle spasms.

 

HB 2677 has been assigned to the House Prevention and Treatment of Substance Abuse Committee. SB 386 has been assigned to the Senate Health and Human Resources.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s